"Study in hepatocellular carcinoma mouse models shows that Erap1 is critically involved in the process of tumor rejection and assumes a dual role by independently operating on both sides. Direct presentation of two MHC-I-restricted epitopes of a cancer-driving transplantation rejection antigen through Erap1 moderately affected tumor rejection by adoptively transferred T-cell receptor gene-modified T cells in each case."xsd:string